Improving Research Capacity in Cameroon for Studies on HIV-Associated Malignancie

提高喀麦隆艾滋病毒相关恶性肿瘤的研究能力

• 批准号: 8309398
• 负责人: MIROSLAW K GORNY
• 金额: $ 54.91万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-30 至 2016-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8309398
• 关键词: AIDS related cancer; Africa; Awareness; Cameroon; Cancer Control; Clinical; Clinical Sciences; Clinical Treatment; Country; Diagnosis; Early Diagnosis; Early treatment; Education; Educational process of instructing; Epidemiology; Goals; HIV; HIV Infections; Health; Human Resources; Incidence; Institution; Knowledge; Laboratories; Laboratory Technicians; Lead; Malignant Neoplasms; Measures; Nurses; Patient Care; Patients; Physicians; Population; Prevention; Preventive; Research; Research Training; Satellite Viruses; Science; Scientist; Signs and Symptoms; Social Workers; Training; antiretroviral therapy; base; burden of illness; improved; innovation; interdisciplinary approach; prevent; programs; skills; transmission process; tumor

DESCRIPTION (provided by applicant): There has been a significant increase in the burden of AIDS-related malignancies and other virus- associated tumors in the countries of Africa. However, with the recent expanded access of antiretroviral therapy (ART), the epidemiology, treatment and clinical results of HIV-associated malignancies are rapidly evolving. In Cameroon, the incidence of cancers in patients with HIV infection has increased steadily. Treatment and use of ART still remain unavailable or inaccessible to most patients with HIV or HlV-related cancers. Building HIV-associated control capacity in Cameroon is critical. There is a need for the provision of training and of facilities for early diagnosis and treatment for effective HIV-cancer associated control. There is a need to increase the awareness of the population in Cameroon about HIV and HIV-associated cancers by teaching basic preventive health measures. For this, research and clinical personnel have to be trained to recognize the early signs and symptoms and integrate HIV-cancer control activities. The goal of this program is to build a sustainable research capacity to study HIV and HIV-associated malignancies at institutions in Cameroon and to provide a steady flow of innovative science-based education. The programs at the institutions with which we partner will strengthen scientific knowledge and skills, enhancing prevention, diagnosis, treatment and care for patients infected with HIV-associated malignancies. Our multidisciplinary approach will be focused on research training for physicians, laboratory technicians, nurses, social workers, and basic scientists. Our approach is crucial to our goal of preventing HIV transmission and reducing the burden of disease on the infected patients in Cameroon. In order to accomplish our main goal we propose: Aim # 1: To establish critical biomedical, laboratory and clinical science expertise in Cameroon; Aim # 2: To facilitate new research efforts aimed at prevention, diagnosis and treatment of HIV and HIV- associated malignancies; Aim # 3: To establish long-term collaborative relationships between NYUSoM and scientists in Cameroon; and. Aim # 4: To integrate the training into ongoing prevention, diagnosis and treatment research efforts in Cameroon. RELEVANCE: This program will lead to the capacity building and scientific enrichment of health workers as a way to prevent HIV and HIV associated malignancies from progressing further.

描述（由申请人提供）：非洲国家的与艾滋病相关的恶性肿瘤和其他与病毒相关的肿瘤的负担显着增加。然而，随着抗逆转录病毒疗法（ART）的最新扩展，与HIV相关的恶性肿瘤的流行病学，治疗和临床结果正在迅速发展。在喀麦隆，艾滋病毒感染患者的癌症发生率稳步增加。对于大多数艾滋病毒或HLV相关癌症患者而言，艺术的治疗和使用仍然无法获得或无法访问。喀麦隆建立与HIV相关的控制能力至关重要。需要提供培训和设施，以进行早期诊断和治疗，以进行有效的HIV-CACTER相关对照。 有必要通过教授基本的预防性健康措施来提高喀麦隆人口对艾滋病毒和艾滋病毒相关癌症的认识。为此，必须对研究和临床人员进行培训，以识别早期体征和症状并整合艾滋病毒 - 癌症控制活动。该计划的目的是建立可持续的研究能力，以研究喀麦隆机构的艾滋病毒和与艾滋病毒相关的恶性肿瘤，并提供基于创新的科学教育的稳定流动。我们合作的机构的计划将增强科学知识和技能，增强感染与HIV相关的恶性肿瘤患者的预防，诊断，治疗和护理。我们的多学科方法将集中在医师，实验室技术人员，护士，社会工作者和基础科学家的研究培训上。我们的方法对于防止HIV传播并减轻喀麦隆感染患者的疾病负担至关重要。为了实现我们提出的主要目标：目标1：在喀麦隆建立关键的生物医学，实验室和临床科学专业知识； 目标＃2：促进旨在预防，诊断和治疗HIV和HIV相关的恶性肿瘤的新研究； 目标＃3：在喀麦隆建立Nyusom与科学家之间的长期合作关系；和。 目标＃4：将培训纳入喀麦隆正在进行的预防，诊断和治疗研究工作。相关性：该计划将导致能力建设和科学丰富卫生工作者，以防止艾滋病毒和艾滋病毒相关的恶性肿瘤进一步发展。